- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Justin Bachmann: Challenges of Implementing Behavioral Interventions in Cardiac Care
The biggest challenge of implementing behavioral interventions to improve care for patients with cardiovascular disease is reimbursement models, said Justin Bachmann, MD, MPH, FACC, Cardiologist and Clinical Investigator, Instructor of Medicine and Health Policy, Vanderbilt University Medical Center.
Transcript
What are the challenges of implementing behavioral interventions to improve care for patients with cardiovascular disease?
The major challenge of this kind of care, and really of cardiac rehabilitation in general, is reimbursement models. Cardiac rehab has 1 reimbursement model, and it largely occurs within the institution outpatient setting, and the hospital outpatient setting. So, we really need some new reimbursement models. Things like home base rehabilitation and new ways to reimburse those types of models. Right now, we don’t really have many, so it’s just working within the reimbursement structures of Medicare and third-party insurers. Also, getting hospital systems and payers to acknowledge that efforts such as counseling techniques, motivational interviewing by staff and by nurses is important. Interventions such as cardiac rehabilitation are important to help keep patents out of the hospital, to keep them from being readmitted, which is certainly what the data shows. It’s important to bring payers around and also hospital systems and get them to recognize the fact that using these interventions to improve post-acute outcomes really can help keep them out of the hospital and improve their quality of life at home.
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Targeted Treatment May Improve Outcomes in IDH1-Mutated MDS
January 13th 2025A pair of abstracts presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exhibition suggest that IDH1-targeted treatment may improve survival among patients with myelodysplastic syndromes (MDS) with the mutation.
Read More
